(Date:5/15/2008)... AARP commends Governor Paterson,s leadership...nd transparency, ALBANY, N.Y., May 15 /PRNewswire...s a paramount interest in passing the Governor,s p...ss the undue influence that,pharmaceutical compani...,only consumers, pocket books but the treatment th...
(Date:5/15/2008)... , WASHINGTON, D.C. -- May 15, 2008 -- The Socie...s (SCAI) today announced that it will hold its 200...sars Palace, Las Vegas. The focused, collegial int... February or early March meeting time beginning in...s will be the premier interventional cardiology me...
(Date:5/15/2008)... OAKLAND, Calif., May 15 /PRNewswire-FirstCal...tion (the "Company") today announced that, on May,...tion Letter stating that,the Company,s requests fo...as been denied. The NASDAQ noted that the Company ...bility to achieve near term compliance with,the co...
(Date:5/15/2008)... PRINCETON, N.J., May 15 /PRNewswire-FirstCal...l stage pharmaceutical company committed to,discov...to treat viral,infections, reported unaudited fina...March 31, 2008. Pharmasset reported a net loss att... or ($0.57) per share for the,quarter ended March ...
Breaking Medicine News(10 mins):Health News:AARP Statement on Governor's Bill for Prescription Drug Marketing Reform and Transparency 2Health News:SCAI announces 2009 annual scientific sessions in Las Vegas 2Health News:WorldHeart Announces Possible Delisting Action by NASDAQ 2Health News:WorldHeart Announces Possible Delisting Action by NASDAQ 3Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 2Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 3Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 4Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 5Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 6Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 7Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 8... on Sunday to Harbin, a major Chinese city of 3.8 ...emical spill. However, people have been warned it ...ice had been suspended since Tuesday, after author...ted the Songhua River following a chemical plant e...
...diet has been widely talked about and largely acce...cted in France which proclaims that there is a 15%...mption of a Mediterranean diet for a period of thr...n and women who were at moderate risk for heart di...
...ttained success in curtailing the spread of AIDS a...g new targets and milestones, However the challeng... The fight against AIDS is well reflected by surve...al mothers where the prevalence rate has fallen fr...
...f Australia that of Queensland has conducted a res...e family to remain fit and healthy. The study was ...in curing the problem of teenage obesity. // In th...h Al Mamun from UQ's School of Population Health, ...
Other Medicine News:Health News:Running Water Restored In Chinese City 2Health News:Curtailing AIDS - The Fight has to Go On 2(Date:5/15/2008)...s for an Antiplatelet Therapy that, Combined, with...n of Plavix/Iscover and Aspirin, According to ...ss., May 15 /- Decision Resources, on...ms for pharmaceutical and,healthcare issues, finds...provement in patient compared to Sanofi-Aventis/Br...
(Date:5/15/2008)...fter CEA Trial data reports in third quarter ...y 15 /- VIA Pharmaceuticals...ocused on the development of,compounds for the tre...that,it has completed patient enrollment in its ac...s one of three Phase 2 trials investigating VIA-22...
(Date:5/15/2008)... Annual Meeting of The American Society of ...-, IRVINE, Calif., May 15 /PRNewswire-FirstCall/ ... today announced the presentation of updated data,...amurtide (L-MTP-PE) in,patients with lung metastas... a rare and often fatal bone tumor that typically ...
(Date:5/14/2008)... /- Progen,Pharmaceuticals ...at the,Company has resumed patient enrolment in th...quired polyamine analogue, PG-11047 (formerly CGC-... has commenced development of PG-11047 - the lead ...am - following its acquisition of,Cellgate, Inc ea...
Breaking Medicine Technology:Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2CoAxia 28TM 29 Announces 2411 5M Equity Financing From Existing Investors 1669 1CoAxia 28TM 29 Announces 2411 5M Equity Financing From Existing Investors 1669 2Avandia May Slow Atherosclerosis After Bypass Surgery 15707 1Avandia May Slow Atherosclerosis After Bypass Surgery 15707 2Avandia May Slow Atherosclerosis After Bypass Surgery 15707 3NASA launches airborne study of arctic atmosphere air pollution 2708 1NASA launches airborne study of arctic atmosphere air pollution 2708 2NASA launches airborne study of arctic atmosphere air pollution 2708 3Daytime TV Addresses the Onslaught of MRSA Cases in U S 15703 1Daytime TV Addresses the Onslaught of MRSA Cases in U S 15703 2... Statistically Significant Changes in,Agitation Le...6, 2007 /PRNewswire-FirstCall/ --,Alexza Pharmaceu...lts from its Phase IIa clinical trial of AZ-004 (S...h acute agitation. The 10 mg,dose of AZ-004 met th...s a statistically-significant reduction in the mea...
...esented at Keystone Scientific Meeting, SOUTH SAN ...tCall/ -- Rigel today announced that Yonchu,Jenkin...presenting,on the company,s efforts to develop a s...he Human Immunodeficiency Virus (HIV),infection at...ch,27th and 29th. Dr. Jenkins will present both a ...
Other Medicine Technology:Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 2Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 3The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets.
The lower body blanket is utilized during surgical procedures covering the head, neck, arms and upper torso of your patient.
The Thermal pads were designed to simulate water immersion, the most effective method of transferring energy non-invasively.
This blanket is ideal for warming the large child or small adult during upper body surgery.
Medicine Products: